1. Guest, the 'News in Brief' for the week beginning 3rd August 2020 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS, 2020, Tokunaga et al

Discussion in 'BioMedical ME/CFS Research' started by Andy, Jun 23, 2020.

  1. Andy

    Andy Committee Member & Outreach

    Messages:
    10,123
    Likes Received:
    73,687
    Location:
    Hampshire, UK
    Paywall, https://content.iospress.com/articles/work/wor203177
    Sci hub, https://sci-hub.tw/10.3233/WOR-203177
     
    Sly Saint, Rosie, Sean and 7 others like this.
  2. strategist

    strategist Senior Member (Voting Rights)

    Messages:
    2,959
    Likes Received:
    29,263
    For those interested in biomarker discovery and quality control, this seems interesting. Maybe also of interest to @Jonathan Edwards. I'm trying to summarize:

    They were 55% higher. Non-classical monocytes are described as anti-inflammatory and being involved in maintenance of vascular homeostasis.

    I also think that families with multiple cases of ME/CFS could be very valuable for research for the reasons mentioned above. Not just to prevent false positives in biomarker research but also to identify the genetic and environmental risk factors.
     
    Last edited: Jun 28, 2020

Share This Page